Predicting Axillary Response in Hormone Receptor-Positive Breast Cancer after Neoadjuvant Chemotherapy Using Real-World Data.
Jie QiuYiwen ZhengDa QianDandan GuanQinghui ZhengYuhao XuSiyi JuXuli MengHongchao TangPublished in: Journal of oncology (2022)
The prediction model showed good performance for HR + breast cancer. LVI, BCS, low Ki-67, HER2 negativity, suspected positive LNs before surgery, and stage III histological grade were all risk factors for residual positive axillary LNs. However, unlike pathological stages, achieving pCR in the axillary LNs does not affect the survival status.
Keyphrases
- neoadjuvant chemotherapy
- positive breast cancer
- sentinel lymph node
- lymph node
- locally advanced
- coronary artery bypass
- pulmonary embolism
- electronic health record
- rectal cancer
- radiation therapy
- early stage
- machine learning
- free survival
- atrial fibrillation
- ultrasound guided
- artificial intelligence
- breast cancer risk